CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+14.98%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$787M
AUM Growth
+$273M
(+53%)
Cap. Flow
+$226M
Cap. Flow
% of AUM
28.71%
Top 10 Holdings %
Top 10 Hldgs %
30.43%
Holding
459
New
34
Increased
332
Reduced
39
Closed
19
Top Buys
| 1 |
Microsoft
MSFT
|
$18.2M |
| 2 |
NVIDIA
NVDA
|
$11.9M |
| 3 |
Netflix
NFLX
|
$9.94M |
| 4 |
Amazon
AMZN
|
$7.89M |
| 5 |
Meta Platforms (Facebook)
META
|
$7.84M |
Top Sells
| 1 |
Vanguard World Funds Extended Duration ETF
EDV
|
$3.64M |
| 2 |
Walmart
WMT
|
$3.08M |
| 3 |
Alibaba
BABA
|
$2.59M |
| 4 |
XYZ
Block, Inc.
XYZ
|
$2.4M |
| 5 |
Intel
INTC
|
$2.07M |
Sector Composition
| 1 | Technology | 37.36% |
| 2 | Healthcare | 29.98% |
| 3 | Consumer Discretionary | 13.6% |
| 4 | Communication Services | 8.97% |
| 5 | Financials | 3.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
ChargePoint
CHPT
$245M
| $181K | 0.02% |
4,750
| – | – |
|
302
Regenxbio
RGNX
$464M
| $179K | 0.02% |
8,519
+3,426
| +67% | +$72.2K |
|
303
Veeva Systems
VEEV
$43.9B
| $179K | 0.02% |
771
| – | – |
|
304
CoStar Group
CSGP
$37.4B
| $178K | 0.02% |
1,842
+1,026
| +126% | +$99.1K |
|
305
Oric Pharmaceuticals
ORIC
$1.01B
| $178K | 0.02% |
12,922
+6,617
| +105% | +$91K |
|
306
MacroGenics
MGNX
$119M
| $176K | 0.02% |
11,935
+4,761
| +66% | +$70.1K |
|
307
Trade Desk
TTD
$25.4B
| $175K | 0.02% |
2,007
+1,127
| +128% | +$98.5K |
|
308
Arcturus Therapeutics
ARCT
$450M
| $174K | 0.02% |
5,153
+2,064
| +67% | +$69.7K |
|
309
Schrodinger
SDGR
$1.4B
| $173K | 0.02% |
6,410
| – | – |
|
310
Pliant Therapeutics
PLRX
$98.2M
| $173K | 0.02% |
11,581
+4,652
| +67% | +$69.3K |
|
|
AUTL
311
Autolus Therapeutics
AUTL
$383M
| $172K | 0.02% |
27,034
+10,771
| +66% | +$68.7K |
|
|
BCYC
312
Bicycle Therapeutics
BCYC
$474M
| $171K | 0.02% |
6,859
+2,858
| +71% | +$71.2K |
|
313
Exelon
EXC
$43.6B
| $169K | 0.02% |
4,508
+2,505
| +125% | +$94.1K |
|
314
Zoetis
ZTS
$67.5B
| $167K | 0.02% |
986
| – | – |
|
315
Cognizant
CTSH
$34.9B
| $165K | 0.02% |
2,246
+1,246
| +125% | +$91.3K |
|
316
Electronic Arts
EA
$41.7B
| $160K | 0.02% |
1,206
+671
| +125% | +$89K |
|
317
Diamondback Energy
FANG
$41.3B
| $160K | 0.02% |
805
+452
| +128% | +$89.6K |
|
318
Zoom
ZM
$24.7B
| $160K | 0.02% |
2,440
| – | – |
|
319
Grifois
GRFS
$6.72B
| $157K | 0.02% |
23,461
+9,350
| +66% | +$62.5K |
|
320
Prime Medicine
PRME
$583M
| $157K | 0.02% |
22,378
+11,120
| +99% | +$77.8K |
|
321
Tango Therapeutics
TNGX
$720M
| $155K | 0.02% |
19,569
+7,776
| +66% | +$61.7K |
|
322
CDW
CDW
$21.5B
| $155K | 0.02% |
605
+339
| +127% | +$86.7K |
|
323
Evolus
EOLS
$474M
| $154K | 0.02% |
10,969
+4,355
| +66% | +$61K |
|
324
Cullinan Oncology
CGEM
$407M
| $153K | 0.02% |
8,996
+4,042
| +82% | +$68.9K |
|
325
Zai Lab
ZLAB
$3.33B
| $153K | 0.02% |
9,530
+3,728
| +64% | +$59.7K |
|